March 21, 2024
The information on this site is not intended to take the place of your doctor or other healthcare professionals. It is a resource to help you make the best decisions and get the most from the medical services available to you. A licensed physician should be consulted for diagnosis and treatment of all medical conditions.
On March 6, 2024, Thea Pharmaceuticals recalled one lot of Betimol (timolol ophthalmic solution) 0.5%, 15ml due to a potential quality defect. This defect can compromise the container closure which may expose patients to bacterial contamination. Betimol is a non-selective beta-adrenergic antagonist used for the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. For more information about the recall, see here.
Last updated: March 21, 2024